Literature DB >> 18220420

Solution NMR characterizations of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2.

Kang Chen1, Indra Bachtiar, Grzegorz Piszczek, Fadila Bouamr, Carol Carter, Nico Tjandra.   

Abstract

Budding of retroviruses requires the structural precursor polyprotein, Gag, to target the plasma membrane through its N-terminal matrix (MA) domain. For HIV-1, the interaction between membrane signaling molecule phosphatidylinositol 4,5-diphosphate (PIP2) and MA induces the exposure of myristate and promotes membrane binding. Here we studied oligomerization of the naturally unmyristylated equine infectious anemia virus (EIAV) MA and its interaction with PIP2-C4 primarily using solution NMR spectroscopy. The measured 1H-15N residual dipolar coupling agrees with the atomic coordinates from the EIAV MA crystal structure. The analytical ultracentrifugation results show a dominant population of monomeric EIAV MA at a concentration of 63 microM and 20 degrees C, along with a small trimer and a broad distribution of other oligomers. The monomer-trimer equilibrium model and the quaternary packing of the trimer were further established by the concentration-dependent 15N spin relaxation rates and chemical shifts. Binding of MA to PIP2-C4 was detected by chemical shift mapping (CSM) with an apparent Kd of 182 +/- 56 microM, a value similar to that reported for HIV-1 MA. The PIP2 binding site includes the Loop region between Helix2 and Helix3 in the EIAV MA. CSM and spin relaxation dispersion reveal a coupling of conformational change and submillisecond dynamics, respectively, between the Loop and trimeric Interface Residues due to PIP2 binding. We infer that PIP2 participates in the initial trimer formation of EIAV MA, but more importantly, the concentration effect is dominant in shifting the equilibrium toward trimer, in line with the entropic switch mechanism proposed for myristylated HIV-1 MA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18220420      PMCID: PMC3120113          DOI: 10.1021/bi701984h

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  36 in total

Review 1.  Synthetic multivalent ligands in the exploration of cell-surface interactions.

Authors:  L L Kiessling; J E Gestwicki; L E Strong
Journal:  Curr Opin Chem Biol       Date:  2000-12       Impact factor: 8.822

2.  Modulation of HIV-like particle assembly in vitro by inositol phosphates.

Authors:  S Campbell; R J Fisher; E M Towler; S Fox; H J Issaq; T Wolfe; L R Phillips; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

Review 3.  Nuclear magnetic resonance methods for quantifying microsecond-to-millisecond motions in biological macromolecules.

Authors:  A G Palmer; C D Kroenke; J P Loria
Journal:  Methods Enzymol       Date:  2001       Impact factor: 1.600

4.  Solution structure of a viral DNA repair polymerase.

Authors:  M W Maciejewski; R Shin; B Pan; A Marintchev; A Denninger; M A Mullen; K Chen; M R Gryk; G P Mullen
Journal:  Nat Struct Biol       Date:  2001-11

5.  Structure of equine infectious anemia virus matrix protein.

Authors:  Hideki Hatanaka; Oleg Iourin; Zihe Rao; Elizabeth Fry; Alan Kingsman; David I Stuart
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Point mutations in the HIV-1 matrix protein turn off the myristyl switch.

Authors:  Jamil S Saad; Erin Loeliger; Paz Luncsford; Mellisa Liriano; Janet Tai; Andrew Kim; Jaime Miller; Anjali Joshi; Eric O Freed; Michael F Summers
Journal:  J Mol Biol       Date:  2006-12-01       Impact factor: 5.469

7.  Binding of equine infectious anemia virus matrix protein to membrane bilayers involves multiple interactions.

Authors:  P Provitera; F Bouamr; D Murray; C Carter; S Scarlata
Journal:  J Mol Biol       Date:  2000-02-25       Impact factor: 5.469

8.  Human immunodeficiency virus type 1 matrix protein assembles on membranes as a hexamer.

Authors:  Ayna Alfadhli; Doug Huseby; Eliot Kapit; Dalbinder Colman; Eric Barklis
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

9.  Backbone dynamics of calmodulin studied by 15N relaxation using inverse detected two-dimensional NMR spectroscopy: the central helix is flexible.

Authors:  G Barbato; M Ikura; L E Kay; R W Pastor; A Bax
Journal:  Biochemistry       Date:  1992-06-16       Impact factor: 3.162

10.  Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane.

Authors:  Akira Ono; Sherimay D Ablan; Stephen J Lockett; Kunio Nagashima; Eric O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-01       Impact factor: 11.205

View more
  38 in total

1.  Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4,5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag.

Authors:  Jingga Inlora; Vineela Chukkapalli; David Derse; Akira Ono
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

2.  Using NMR to distinguish viscosity effects from nonspecific protein binding under crowded conditions.

Authors:  Conggang Li; Gary J Pielak
Journal:  J Am Chem Soc       Date:  2009-02-04       Impact factor: 15.419

3.  Rous sarcoma virus gag has no specific requirement for phosphatidylinositol-(4,5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro.

Authors:  Jany Chan; Robert A Dick; Volker M Vogt
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

Review 4.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

5.  Protein targeting to exosomes/microvesicles by plasma membrane anchors.

Authors:  Beiyi Shen; Ning Wu; Jr-Ming Yang; Stephen J Gould
Journal:  J Biol Chem       Date:  2011-02-07       Impact factor: 5.157

6.  Assembly and replication of HIV-1 in T cells with low levels of phosphatidylinositol-(4,5)-bisphosphate.

Authors:  Kazuaki Monde; Vineela Chukkapalli; Akira Ono
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

Review 7.  HIV type 1 Gag as a target for antiviral therapy.

Authors:  Abdul A Waheed; Eric O Freed
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-21       Impact factor: 2.205

8.  Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein.

Authors:  Shorena Nadaraia-Hoke; Darrin V Bann; Timothy L Lochmann; Nicole Gudleski-O'Regan; Leslie J Parent
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  Defining the epitope region of a peptide from the Streptomyces coelicolor phosphoenolpyruvate:sugar phosphotransferase system able to bind to the enzyme I.

Authors:  Estefanía Hurtado-Gómez; Olga Abián; F Javier Muñoz; María José Hernáiz; Adrián Velázquez-Campoy; José L Neira
Journal:  Biophys J       Date:  2008-05-02       Impact factor: 4.033

10.  Basic residues in the matrix domain and multimerization target murine leukemia virus Gag to the virological synapse.

Authors:  Fei Li; Jing Jin; Christin Herrmann; Walther Mothes
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.